Pomalidomide-amino-PEG5-NH2 hydrochloride|CAS 2421217-05-0|DC Chemicals

Cas No.:	2421217-05-0
Chemical Name:	Acetamide, 2-[(14-amino-3,6,9,12-tetraoxatetradec-1-yl)oxy]-N-[2-(2,6-dioxo-3-piperidinyl)-2,3-dihydro-1,3-dioxo-1H-isoindol-4-yl]-, hydrochloride (1:1)
Synonyms:	Acetamide, 2-[(14-amino-3,6,9,12-tetraoxatetradec-1-yl)oxy]-N-[2-(2,6-dioxo-3-piperidinyl)-2,3-dihydro-1,3-dioxo-1H-isoindol-4-yl]-, hydrochloride (1:1)
SMILES:	O=C1N(C2CCC(=O)NC2=O)C(=O)C2=CC=CC(NC(=O)COCCOCCOCCOCCOCCN)=C12.Cl
Formula:	C₂₅H₃₅ClN₄O₁₀
M.Wt:	587.019206285477
Purity:	>98%
Sotrage:	2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO

MSDS

COA

Cat. No.	Product name	Field of application
DC45712	Pomalidomide-amino-PEG3-NH2 hydrochloride	Pomalidomide-amino-PEG3-NH2 hydrochloride is a synthesized E3 ligase ligand-linker conjugate that incorporates the Pomalidomide based cereblon ligand and a linker used in PROTAC technology.
DC45710	Pomalidomide-amino-PEG5-NH2 hydrochloride	Pomalidomide-amino-PEG5-NH2 hydrochloride is a synthesized E3 ligase ligand-linker conjugate that incorporates the Pomalidomide based cereblon ligand and a linker used in PROTAC technology.
DC45705	Thalidomide-NH-PEG1-NH2 hydrochloride	Thalidomide-NH-PEG1-NH2 hydrochloride is a synthesized E3 ligase ligand-linker conjugate that incorporates the Thalidomide based cereblon ligand and a linker used in PROTAC technology.
DC40565	KB02-COOH	KB02-COOH is a fragment of synthesis of ubiquitin E3 ligase ligand KB02. KB02 can be used in the synthesis of PROTAC, such as KB02-JQ1 and KB02-SLF.
DC28654	NH2-PEG6-Boc	NH2-PEG6-Boc is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs. NH2-PEG6-Boc is also a non-cleavable 6 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs).
DC11574	E3 Ligand-Linker Conjugate 8	An E3 ligase ligand-linker conjugate for PROTAC..
DC11573	E3 Ligand-Linker Conjugate 7	An E3 ligase ligand-linker conjugate for PROTAC..
DC11572	E3 Ligand-Linker Conjugate 6	An E3 ligase ligand-linker conjugate for PROTAC..